Cadila Healthcare share price surges 8% as DGCI approves indigenous ZyCov-D covid vaccine – check target price here
Amid approval of ZyCov-D covid vaccine, the shares of Cadila Healthcare jumped almost 8 per cent to Rs 576.25 per share on the BSE intraday trade on Monday. The majority of the brokerages, however, are divided on the stock price of pharma major either with sell, buy or equal-weight rating.
ZyCov-D of Cadila Healthcare is the sixth Covid Vaccine to approved in India: PTI